Trailing Twelve Months Sales Growth: Upstream Bio Inc (UPB)

Graphic logo of Upstream Pharma (UPB)

Upstream Bio Inc (UPB) faces geopolitical risks regarding patent protection and is managing capital expenditure during the testing of immunotherapeutic drugs. The GURU.Markets system provides the annual revenue growth trend over a rolling 12-month period, where 2.60 characterizes this valuation parameter. Business development relies on partnerships with laboratories to create medications for allergies and asthma.

Revenue Growth YoY (Last 12 Months): upstreambio.com (UPB) for 11/23/2025 - 11/15/2026

Upstream Pharma (UPB) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price Upstream Pharma|UPB - Price Target Chart
- company stock exchange capitalization indicators:
Market Valuation Upstream Bio, Inc.|UPB - Total Company Value
- book capitalization indicators:
Net Assets per Share Upstream Bio|UPB - Company Net Assets|Market Cap to Book Value Multiple upstreambio.com|UPB - Aggregate Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Upstream Bio Inc|UPB - Long-Term Debt to Capital|Current Liabilities to Capital Upstream Bio|UPB - Company Aggregate Debts|Debts to Book Capitalization Upstream Bio, Inc.|UPB - Company Long-Term Debt|Company Current Liabilities Upstream Bio|Intermediate Coverage Ratio upstreambio.com
- company profitability and valuation multiples indicators:
UPB - Net Profit|Expected Profit Upstream Bio Inc|UPB - P/E Multiple|Market Cap to Projected Earnings upstreambio.com|UPB - Price/Earnings to Growth Ratio|Company Value to EBITDA Upstream Bio Corp|UPB - Operating profit before deduction of amortization|Earnings per share for the trailing year Upstream Bio|UPB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months upstreambio.com|UPB - Earnings per share growth in current year|Projected earnings per share growth rate for next year Upstream Bio Inc
- sales and revenue indicators:
UPB - Revenue and Sales Volume|Company Future Sales Volume Upstream Bio Inc|UPB - Market Cap to Revenue|Forward P/S Multiple Upstream Bio, Inc.|UPB - Sales Growth YoY (Last Twelve Months)
Summary company analytics:UPB (Upstream Pharma)
Brand item of Upstream Bio Corp

To minimize fundamental risks, investors should select assets with sustainable revenue expansion, which this metric calculates as the percentage change in total income over the last twelve months relative to the same period last year. In the context of immune drug development, Upstream Bio Inc (UPB) operating revenue growth YoY (TTM) reflects the commercial efficiency of innovations and the success of clinical trials.

Competitors of Upstream Bio Inc (UPB)

Argenx (ARGX) - Trailing Twelve Months Revenue Growth|BioNTech SE - Sales Growth YoY (TTM)|ABVX - Sales Growth YoY (TTM)|ADMA: Sales Growth YoY (TTM)|Protagonist Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Immunovant Therapeutics|Sales Growth YoY (Last 12 Months) KNSA (Kiniksa Pharmaceuticals Ltd)|Sales Growth YoY (TTM) GRFS|ADPT: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) CLDX (Celldex)|AUPH: Sales Growth YoY (Last 12 Months)|BCRX: Revenue Growth YoY (Last 12 Months)|Vera Pharma - Revenue Change YoY (Last 12 Months)|DNTH (Dianthus Corp) - Revenue Growth YoY (Last 12 Months)|Pharvaris N.V. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) AbCellera Biologics|Tourmaline Bio Inc (TRML) - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) PGEN (Intrexon)|PHAR (Pharming) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) NKTR (Nektar Therapeutics Inc)|ZBIO (Zenas Biopharma Inc) - Trailing Twelve Months Sales Growth|IMNM - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Gossamer Bio Inc GOSS|KALV: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Septerna Pharma|PVLA (Pieris Corp) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) SVRA|Sales Growth YoY (TTM) RIGL|Revenue Growth YoY (Last 12 Months) AnaptysBio Corp ANAB|Astria Therapeutics Inc - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Revenue Growth YoY (Last 12 Months)|KYTX: Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Tiziana Life Sciences|Cabaletta Bio, Inc (CABA) - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) VTYX (Ventyx Biosciences)|Annual Revenue Growth (Last Twelve Months) theratech.com|Sales Growth YoY (TTM) AVTX (Avalo Therapeutics, Inc.)|Sales Growth YoY (TTM) Eledon Pharmaceuticals Inc. ELDN|AGEN: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) CLYM (Climb Bio, Inc)|ZURA: Sales Growth YoY (TTM)|aTyr Pharma, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Adagene Inc.|IMA: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) STTK|Revenue Growth YoY (Last 12 Months) Equillium Bio EQ|Sales Growth YoY (Last Twelve Months) Connect Biopharma CNTB|IMUX - Revenue Growth YoY (Last 12 Months)|ATRA - Sales Growth YoY (Last Twelve Months)|InflaRx NV (IFRX) - Revenue Growth YoY (Last 12 Months)|XFOR (X4 Pharmaceuticals Inc.) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Adicet Bio Inc. (ACET)|Sales Growth YoY (Last Twelve Months) celularity.com|Revenue Growth YoY (Last 12 Months) inmunebio.com (INMB)|Sales Growth YoY (Last Twelve Months) Barinthus Biotherapeutics PLC (BRNS)|Annual Revenue Growth (Last Twelve Months) Kezar Life Sciences Inc.|SAB Biotherapeutics, Inc - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Akari Therapeutics, Plc (AKTX)|ENLV: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QTTB (q32bio.com)|GeoVax Labs Inc (GOVX) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Edesa|Sales Growth YoY (Last Twelve Months) iBio, Inc.|Revenue Growth YoY (Last 12 Months) carismatx.com (CARM)|Sales Growth YoY (TTM) XTLB|Revenue Growth YoY (Last 12 Months) Bolt Bio BOLT|Sales Growth YoY (TTM) HCWB (HCW Biologics)|APVO: Sales Growth YoY (Last 12 Months)|AIM - Sales Growth YoY (Last Twelve Months)|ADTX - Sales Growth YoY (TTM)|GRI Bio (GRI) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XORTX Therapeutics|Sales Growth YoY (Last Twelve Months) Vyome Therapeutics|Sales Growth YoY (Last 12 Months) REVB (Revelation Biosciences, Inc.)|Sales Growth YoY (TTM) INDP|Revenue Growth YoY (Last 12 Months) Scinai Immunotherapeutics SCNI|Sales Growth YoY (TTM) CALI (CalciMedica)|AFMD - Revenue Growth YoY (Last 12 Months)|ALLK: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) HOOKIPA Pharma HOOK|IGMS: Sales Growth YoY (TTM)|ITOS: Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Ocean Biomedical|tcbiopharm.com - Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Third Harmonic Bio, Inc. (THRD)